Skip to content
★ Sign in to follow
Shanghai ZJ Bio-Tech Co., Ltd logo

Shanghai ZJ Bio-Tech Co., Ltd Stock: price and insider trades · China

之江生物

CN·Mcap CN¥3.2BHealth Care

No insider purchase over the last 90 days. The latest, by 倪卫琴, was filed 05 Feb 2024.

Shanghai ZJ Bio-Tech Co., Ltd: what insiders have been doing

Shanghai ZJ Bio-Tech Co., Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Shanghai ZJ Bio-Tech Co., Ltd has published a filing in the past twelve months. The most recent one dates from 5 February 2024.

Since 2021, the database holds 5 purchases and no sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
5
Thresholds
n/a
Buy Volume
€342,152
5 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 05 Feb 2024 · 1007 days ago · €66k
    +16.5%
    Entry CN¥13.84 · Close at T+365 CN¥16.12
  • Filed 26 Jan 2022 · 1747 days ago · €65k
    -21.4%
    Entry CN¥43.60 · Close at T+365 CN¥34.26

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 20,156 of 26,897 companies
34.5
score / 100
Value
39
Quality
30
FCF yld2.0%
Earn yld-1.1%
EV/EBITDA·
ROE-1.9%
Gross mgn64%
Net mgn-27%
Debt/EBITDA10.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥16.97
Analyst consensus
·
Income statement
RevenueCN¥124.8M
Gross profitCN¥80.1M64% margin
EBITDACN¥27.4M22% margin
Net income-CN¥34.3M-54.9% margin
Valuation
P/Book0.9x
Beta0.60
Balance sheet & cash
Market capCN¥3.2B
Total debtCN¥299M
Free Cash FlowCN¥64.9M
Debt / Equity9%
Profitability & ownership
ROE-1.9%
ROA-1.5%
% insiders42.1%
% institutions2.2%
Last declaration on 5 February 2024
Declarations5 total
  • ▲
    董事,高级管理人员Executives
    510,471 CNY15SSE
    39,000 shares100.0% of flowA股XSHGSSE:173000007307411360
    Canonical exit: 5 May 2024 (T+90)
  • ▲
    董事Executives
    464,790 CNY9SSE
    10,000 shares23.5% of flowA股XSHGSSE:173000005250145760
    Canonical exit: 26 Apr 2022 (T+90)
  • ▲
    董事,核心技术人员Executives
    581,980 CNY10SSE
    10,000 shares29.2% of flowA股XSHGSSE:173000005229776900
    Canonical exit: 19 Apr 2022 (T+90)
  • ▲
    董事,核心技术人员Executives
    475,400 CNY9SSE
    10,000 shares23.2% of flowA股XSHGSSE:173000005038718900
    Canonical exit: 1 Feb 2022 (T+90)
  • ▲
    董事,核心技术人员Executives
    509,700 CNY9SSE
    10,000 shares24.2% of flowA股XSHGSSE:173000004826181540
    Canonical exit: 12 Dec 2021 (T+90)

5 of 5 declarations

About Shanghai ZJ Bio-Tech Co., Ltd

之江生物 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative biological solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations